New Breast Cancer Drug Ribociclib (Kisqali) May Benefit Younger Women, Too

WEDNESDAY, Dec. 6, 2017 — Adding a new drug to standard treatment can slow the progression of advanced breast cancer in younger women, a new clinical trial has found.
The drug, called ribociclib (Kisqali), was approved by the U.S. Food and Drug…
Source: Topamax